Stock data
ResMed Inc. (RMD)
ResMed Inc. (RMD) reported revenue of US$5.65B and net income of US$1.52B for fiscal 2026. The figures below come from the company's SEC filings.
Annual results
Data as of 2026-06-30
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2026 | US$5.65B | US$3.45B | US$1.89B | US$1.52B | — |
| 2025 | US$5.15B | US$3.05B | US$1.69B | US$1.40B | — |
| 2024 | US$4.69B | US$2.66B | US$1.32B | US$1.02B | — |
| 2023 | US$4.22B | US$2.36B | US$1.13B | US$897.56M | — |
| 2022 | US$3.58B | US$2.02B | US$1.00B | US$779.44M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | US$1.46B | US$383.43M | — |
| 2026-03-31 | US$1.43B | US$398.73M | — |
| 2025-12-31 | US$1.42B | US$392.59M | — |
| 2025-09-30 | US$1.34B | US$348.54M | — |
| 2025-06-30 | US$1.35B | US$379.70M | — |
| 2025-03-31 | US$1.29B | US$365.04M | — |
| 2024-12-31 | US$1.28B | US$344.62M | — |
| 2024-09-30 | US$1.22B | US$311.36M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.